New insight into the pathogenesis of atopic dermatitis from analysis of the mutual association between permeability barrier dysfunction and allergic inflammation
Author:
- Yutaka HatanoYHYutaka Hatano
- 1 June 2015
- journal article
- Published by Medknow in Dermatologica Sinica
- Vol. 33 (2) , 74-77
Abstract
The mutual association between permeability barrier dysfunction and allergic inflammation is one of the most important issues in the pathogenesis of atopic dermatitis (AD). Permeability barrier abrogation not only induces cutaneous inflammation, but is also involved in the induction of T helper 2 (Th2)-type immunological reactions. Conversely, Th2 or other cytokines abrogate permeability barrier homeostasis. Some molecules and/or pathogenic factors have been found to be simultaneously involved in both aspects of AD. Decreases in filaggrin or peroxisome proliferator-activated receptor α, which are observed in AD lesions, not only disturb the permeability barrier function but could also directly augment cutaneous inflammation via the upregulation of proinflammatory cytokines. Elevation of the stratum corneum (SC) pH, which is also observed in AD lesions, could initiate and/or drive many of the pathogenic features including both the permeability barrier disturbance and induction of Th2-type inflammation via protease-activated receptor-2-dependent and -independent mechanisms, leading to the emergence and/or exacerbation of AD. Disturbance of the SC pH recovery function is observed in flaky tail mice and might be involved in the susceptibility to AD-like dermatitis of mice with genetic abnormalities associated with permeability barrier function. Disturbed SC acidity maintenance could be regarded as a missing link that connects genetic abnormalities associated with permeability barrier dysfunction and environmental factors in the pathogenesis of ADKeywords
This publication has 37 references indexed in Scilit:
- Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signalingJournal of Allergy and Clinical Immunology, 2012
- Epidermal barrier dysfunction and cutaneous sensitization in atopic diseasesJournal of Clinical Investigation, 2012
- TSLP Expression: Cellular Sources, Triggers, and Regulatory MechanismsAllergology International, 2012
- Induction of eosinophil‐ and Th2‐attracting epidermal chemokines and cutaneous late‐phase reaction in tape‐stripped skinExperimental Dermatology, 2009
- Kallikrein 5 induces atopic dermatitis–like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndromeJournal of Experimental Medicine, 2009
- Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanismsJournal of Allergy and Clinical Immunology, 2008
- Interleukin-4 depresses levels of transcripts for acid-sphingomyelinase and glucocerebrosidase and the amount of ceramide in acetone-wounded epidermis, as demonstrated in a living skin equivalentJournal of Dermatological Science, 2007
- Cytokine modulation of atopic dermatitis filaggrin skin expressionJournal of Allergy and Clinical Immunology, 2007
- Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cellsJournal of Experimental Medicine, 2007
- Interleukin-4 Suppresses the Enhancement of Ceramide Synthesis and Cutaneous Permeability Barrier Functions Induced by Tumor Necrosis Factor-α and interferon-γ in Human EpidermisJournal of Investigative Dermatology, 2005